ClinicalTrials.gg
Sign In

Ductus Arteriosus, Patent clinical trials

The registry lists 146 studies for Ductus Arteriosus, Patent across more than 10 countries. 21 are recruiting or about to start. 116 of them are mainly about Ductus Arteriosus, Patent (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-07.

Get an email when these change. Save the Ductus Arteriosus, Patent studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
73
Status unknown
24
Recruiting
14
Terminated
12
Active, not recruiting
8
Not yet recruiting
7

Phase

Phase 2
27
Phase 3
21
Phase 4
9
Phase 1
4
Early Phase 1
1

Where

United States
40
Italy
11
Turkey
10
Israel
10
Canada
10
France
9

Who runs them

Shaare Zedek Medical Center (8) · Zekai Tahir Burak Women's Health Research and Education Hospital (5) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (5) · Abbott Medical Devices (4) · University of Florida (4) · Assiut University (4) · Albany Medical College (4) · University of Utah (3)

What is being tested here

Drugs under test in Ductus Arteriosus, Patent studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Acetaminophen4623
Ibuprofen1425
Indomethacin039
Solufenum012
Thiamine001
Fenoldopam011
Poractant alfa001
Glucose001
Pentoxifylline001

Drug classes tested here NSAIDs 1 open

Coming up

3phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 14 Ductus Arteriosus, Patent studies recruiting now, 4 (29%) set no upper age limit and 10 (71%) stop at 75 or younger. 14 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (7%) take healthy volunteers.

Recruiting studies that take each age, of 14
AgeWomenMen
104 (29%)4 (29%)
184 (29%)4 (29%)
304 (29%)4 (29%)
404 (29%)4 (29%)
504 (29%)4 (29%)
654 (29%)4 (29%)
754 (29%)4 (29%)
854 (29%)4 (29%)

Across all 146 studies, recruiting or not: 86% stop at 75 or younger and 85% at 65; 99% take children; 1% are for women only and 1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Ductus Arteriosus, Patent studies take

Of 22 observational studies under Ductus Arteriosus, Patent, half reached primary completion within 48 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational48 mo26–65 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 146. Browse all 146 → or search them.